SCHEMBL30879276

SCHEMBL30879276

CC(C)[Si](C#Cc1c(Cc2ccccc2)c(=O)n(C)c2nc(S(C)(=O)=O)ncc12)(C(C)C)C(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.34
KDM4E B2RXH2 5/20 0.34
HPGD P15428 2/20 0.34
CYP2C9 P11712 6/20 0.34
CYP3A4 P08684 4/20 0.34
FPR1 P21462 1/20 0.34
CYP1A2 P05177 7/20 0.33
CYP2C19 P33261 6/20 0.33
TSHR P16473 5/20 0.33
TLR7 Q9NYK1 1/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
CYP2D6 P10635 2/20 0.32
RXFP1 Q9HBX9 1/20 0.32
ABL1 P00519 1/20 0.32
SRC P12931 1/20 0.32
MAPK1 P28482 2/20 0.32
CASP1 P29466 2/20 0.32
CASP7 P55210 2/20 0.32
HSD17B10 Q99714 2/20 0.32
USP2 O75604 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30879030 0.84 ALDH1A1 (0.35) ALDH1A1KDM4EHPGDCYP2C9CYP3A4
SCHEMBL30878809 0.83 PTGS2 (0.34) ALDH1A1KDM4ECYP2C9CYP3A4CYP1A2
SCHEMBL30879076 0.81 WEE1 (0.37) ALDH1A1CYP2C9CYP3A4CYP1A2CYP2C19
SCHEMBL30878873 0.81
SCHEMBL30878746 0.79 WEE1 (0.43) ABL1SRC
SCHEMBL30879095 0.78 RIPK2 (0.37) ABL1SRC
SCHEMBL30879145 0.77 DPP4 (0.34) KDM4EHPGDTSHRHSD17B10LMNA
SCHEMBL30879040 0.77 KDM4E (0.39) ALDH1A1KDM4EHPGDCYP2C9CYP3A4
SCHEMBL30878920 0.77 ALDH1A1 (0.34) ALDH1A1CYP2C9CYP3A4CYP1A2CYP2C19
SCHEMBL30878706 0.77 CYP1A2 (0.37) ALDH1A1KDM4EHPGDCYP2C9CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed